(19)
(11) EP 4 127 719 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
18.12.2024 Bulletin 2024/51

(45) Mention of the grant of the patent:
13.11.2024 Bulletin 2024/46

(21) Application number: 21717178.4

(22) Date of filing: 01.04.2021
(51) International Patent Classification (IPC): 
G01N 33/543(2006.01)
G01N 33/558(2006.01)
 G01N 33/569(2006.01)
(52) Cooperative Patent Classification (CPC):
G01N 2800/26; G01N 33/56972; G01N 2333/70535; G01N 33/543; G01N 33/54388
(86) International application number:
PCT/GB2021/050813
(87) International publication number:
WO 2021/198693 (07.10.2021 Gazette 2021/40)

(54)

METHOD FOR DETECTION OF CD16B

VERFAHREN ZUR DETEKTION VON CD16B

MÉTHODE DE DÉTECTION DE CD16B

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 03.04.2020 GB 202004972

(43) Date of publication of application:
08.02.2023 Bulletin 2023/06

(73) Proprietor: 52 North Health Ltd
Cambridge, Cambridgeshire CB1 2LA (GB)

(72) Inventor:
  • AHMAD, Saif
    Cambridge Cambridgeshire CB2 0AH (GB)

(74) Representative: Boult Wade Tennant LLP 
Salisbury Square House 8 Salisbury Square
London EC4Y 8AP
London EC4Y 8AP (GB)


(56) References cited: : 
WO-A1-02/33408
US-A1- 2013 130 286
 WO-A1-2018/018095
US-A1- 2014 273 018
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).